Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH: L19TNF + Dacarbazine in Advanced Soft Tissue Sarcoma
NCT04733183Phase 2Active, not recruiting
- Sponsor
- Philogen
- Start
- Aug 2020
- Primary completion
- Dec 2025
- Modality
- Antibody Fragments, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 2 trial of onfekafusp alfa in soft tissue sarcoma (STS), sponsored by Philogen. Started Aug 2020; status: active, not recruiting.
02
Drugs
onfekafusp alfa
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04733183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733183.